Big Data, Big Opportunity: A Guide for Dementia Researchers
Chloe Tulip
27 November 2025
I don’t exactly remember the first time I heard the term ‘big data’ but I do know that my first thoughts were- ‘Sounds scary. That’s not for me.’ My own, much smaller, datasets already felt tricky enough to understand and analyse so surely these massive databases were best left to more technical researchers with specialised training. That went into the ‘interesting but not relevant to my work’ mental folder.
I understand why big data feels daunting if working with smaller datasets can already be challenging, these massive databases seem like a whole different level of complexity. But I’ve learned that while big data can certainly present new challenges, it’s not as intimidating as it first appears, especially when you consider the incredible opportunities it offers.
As dementias researchers, we intimately understand how resource-intensive our work can be. Each study is a substantial investment, not just in terms of funding and researcher hours, but also in the invaluable time contributed by participants and their families. The ethical approvals, recruitment challenges, and longitudinal follow-up make collecting new data both expensive and time-consuming.
This is why big data represents such an extraordinary opportunity for our field.
Right now, there are huge sets of data already collected, ethically approved, and waiting for your research questions. Millions of data points from memory clinics, population studies spanning decades, detailed brain scans, genetic profiles, and comprehensive cognitive assessments sit ready to be analysed which are a product of monumental efforts and hours of work.
For example, the UK Biobank is one of the most well-known and widely used resources of its kind. It includes health, lifestyle, genetic, and imaging data from over 500,000 participants across the UK, many of whom have been followed up for more than a decade. The dataset is incredibly rich, covering everything from medical history and medication use to socioeconomic factors, physical measurements, and even accelerometer-based physical activity. On top of that, a large subset of participants have undergone brain, heart, and body imaging, and nearly all have genetic data available.
This means you could, for instance, investigate how early-life risk factors influence later-life cognitive decline, or explore links between cardiovascular health and brain structure. The data are de-identified and access is granted through an application process, making it a powerful yet accessible resource for us.
The benefits of using large-scale datasets is substantial. By building upon established work rather than starting from scratch, we create a cumulative knowledge base that accelerates discovery and propels research forward. Also, these large samples are essential for detecting subtle, population-level patterns that remain invisible in smaller studies. Importantly, they can be used to validate findings across diverse populations and contexts, significantly strengthening the reliability of our conclusions. Ultimately, this approach empowers us to address both complex and fundamental research questions that are impossible to explore within the limited scope of single-site studies.
Yet despite these clear advantages, many researchers still hesitate to engage with big data resources and I completely understand why!
I wish that someone had told me years ago that you don’t need to be a data scientist or a ‘big’ researcher from a super-talented research team to use big data. If you can already analyse your own smaller datasets, can formulate meaningful research questions, and are willing to learn some new tools (with plenty of training resources available), you can absolutely work with these larger datasets, even if you’ve never done so before.
This guide aims to break down the process of accessing and using big data in dementia research into clear, manageable steps. I hope you’ll find it useful as you consider how these resources might enhance your own research journey and help us collectively make faster progress in understanding and treating dementia.
So, what does ‘big data’ actually mean?
The term ‘big data’ can be difficult to pin down precisely. Technically speaking, it often refers to datasets so large and complex that they require specialised processing power or infrastructure to manage, which might sound intimidating at first. But don’t let that definition put you off. A more accessible way to think about big data is simply as large-scale datasets collected from multiple sources that offer rich research possibilities.
In dementias research specifically, these datasets typically include combinations of comprehensive cognitive test results spanning multiple domains, detailed medical and medication histories, and high-resolution brain imaging such as MRI, PET, and CT scans. They often contain genetic information including APOE status and wider genomic data, alongside lifestyle and environmental factors tracked over time. Perhaps most valuable of all, many include longitudinal assessments showing how these measures change over months or years, providing insights into the progression of cognitive changes.
The data may originate from memory clinics, population-based cohort studies, clinical trials, or national health systems in the form of electronic health records (EHRs). What truly makes them ‘big’ isn’t just their storage size in gigabytes, but their depth, complexity, and tremendous research potential.
Where is this data stored?
Patients are at the heart of our research, our efforts are focused to keep their data safe while also enabling research. Therefore, most big datasets are housed in Trusted Research Environments (TRE) which are secure digital platforms designed to give approved researchers access to sensitive data in a protected, controlled way.
TRE’s provide robust security where data never leaves the platform, ensuring compliance with data protection regulations. Privacy is maintained by removing personal identifiers, protecting participant confidentiality. Many TRE’s include a suite of analytical software and packages for collaboration and analysis, making it easier to work with colleagues across institutions.
Several key platforms have become central resources for dementias researchers. Dementias Platform UK (DPUK) provides access to over 60 dementia-related datasets, along with imaging and genomic data. The SAIL Databank, based at Swansea University in Wales, links anonymised electronic health records and administrative data, offering insights into population-level patterns and healthcare utilisation at the national level. UK Biobank’s TRE contains rich imaging and genetic data from large populations. The Office of National Statistics (ONS) also maintains secure research environments with demographic data that can provide important contextual information.
Beyond these formal TRE’s, some big data is stored with organisations that maintain their own security protocols. For instance, the National Alzheimer’s Coordinating Center (NACC) database in the USA allows researchers to download de-identified clinical data directly after completing appropriate data use agreements. These alternative access models can sometimes provide more flexibility while still protecting sensitive information.
How to get started with big data
1. Discover what data exists
Your big data journey begins with exploration. Whether you have a specific research question in mind or are simply curious about what’s available to spark new ideas, start by using discovery tools to browse through cohort directories, metadata browsers, and research resource catalogues. Many platforms offer searchable inventories that allow you to filter by variables of interest, such as specific cognitive measures, biomarkers, or demographic characteristics.
2. Apply for access
Once you’ve identified data that aligns with your research interests, the next step is applying for access. Most datasets require a formal application process, which typically involves outlining your research question and describing your planned analyses in detail. You’ll likely need to demonstrate appropriate ethical approvals and confirm that you have the necessary skills and support, if needed, to handle the data responsibly. Most TREs will ask for research credentials, such as proof of affiliation with a university/bona fide organisation and you may need to sign a data user agreement before access is granted.
Don’t let this step intimidate you! It’s important to remember that access teams exist to help researchers like you, and many provide templates and guidance to simplify the process. A good tip is to be thorough with your application, TREs have a responsibility to ensure that the data is being used appropriately and ethically. Think of it as creating and sharing a complete research protocol, similar to what you might prepare for your own data collection study, just with a focus on secondary analysis.
3. Complete onboarding and training
After your application is approved, you’ll typically receive instructions on how to use the platform and access the data. Each TRE/data bank has its own system, so this step will likely include a learning curve. However, most understand this challenge and provide comprehensive support and materials to help you through the process.
This support often includes guided tutorials, documentation libraries, and sometimes formal training courses. Most importantly, TREs typically offer help desks staffed by people who can troubleshoot any issues you encounter. Remember that everyone starts somewhere, even experienced researchers need guidance when using a new system for the first time.
4. Begin your analysis
Now that you’ve completed the required training and know how to navigate the TRE, it’s time to start your analysis! One of the most reassuring aspects of working in TREs is that many offer access to the same software you might already be familiar with. This could include statistical packages like SPSS, R, or STATA, and access to programming languages like Python and Linux. In DPUK, for example, all analysis happens within the secure portal, but you can use many familiar tools and approaches.
5. Share your results safely
After completing your analysis, it’s time to bring your processed results out into the world. This is where TRE’s demonstrate their commitment to data protection. Most have established systems to ensure all research output is safe to release, meaning it’s checked to confirm that none of the data could lead to the identification of individuals.
This review process is one of the key reasons big data can exist in the first place, because security and anonymisation are top priorities. Most TRE’s provide guidelines on what can be requested out and how. Usually, data analysts will then check your output for anything that might compromise anonymity. If concerns arise, they’ll help you amend your output to make it safe for release.
And with that final step completed, you’ve successfully used big data for your research! Before you publish or present your findings, check the publication policy for your specific dataset. Most TREs require you to follow certain guidelines about how their data can be used in publications. Once you’ve ensured your work meets these requirements, your results can inform publications, presentations, and future research directions, all while maintaining the privacy and security of the individuals whose data contributed to your findings.
What’s possible with big data in dementia research?
The scale and depth of these datasets unlock research possibilities that smaller studies simply cannot achieve. With big data, researchers can identify subtle cognitive changes years before clinical symptoms appear and explore complex interactions between multiple risk factors across diverse populations. These large samples make it possible to examine rare subgroups that would be represented by just a handful of participants in traditional studies.
Recent publications demonstrate big data’s impact on dementia research. Studies have revealed how vascular risk factors interact with genetic predisposition to influence cognitive decline, identified distinct trajectories of decline across different cognitive domains, and how socioeconomic factors throughout life influence dementia risk. These discoveries represent just the beginning of what’s possible when researchers bring their questions to these rich data resources.
Why broader participation matters
Diverse perspectives are essential when working with these datasets. When clinicians, psychologists, social scientists, and researchers from varied backgrounds bring their unique questions to big data, the entire field benefits. We generate more creative research questions, build more clinically relevant evidence, ensure findings are interpreted with appropriate context, and accelerate translation into practice. These datasets were built to be used, and they become exponentially more valuable when examined through multiple disciplinary lenses.
Where to Find Support
Getting started with big data doesn’t mean figuring it out alone. Access teams will provide all necessary information to navigate the portal and address platform-related issues, though they primarily focus on data access rather than extensive analytical guidance (more comprehensive analytical support may come with additional costs at some TRE’s). For developing technical skills, there are numerous resources available online for learning data wrangling, Python programming, or other specialist software tools you might need. For example, training programs and support suits are offered through DPUK Data Portal, Health Data Research UK, SAIL Databank, and many universities offer specialised workshops and courses focused specifically on health data science. Additionally, professional networking with experienced researchers can be invaluable, connecting with colleagues who have complementary skills or joining collaborative projects often provides practical insights that formal documentation cannot.
Final Thoughts
If you’ve been hesitant about working with big data for your dementia research, I hope this guide helps you take that first step. The barriers to entry are lower than you might expect, and the potential benefits, both to your research and to our collective understanding of dementia, are substantial.